Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Goodyear, Arizona 25 trials found
New Search
Filter
Trial Phase
Study Type
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Molecular Genetics Studies of Cancer Patients and Their Relatives
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Pancreatic Cancer Early Detection Consortium
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
N/AOBSERVATIONAL Gilbert, Arizona +4 more
RECRUITING
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2, PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Breast Cancer, Reasoning, and Activity Intervention
NAINTERVENTIONAL Phoenix, Arizona
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
PRE-ISPY Phase I/II Oncology Platform Program
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
FOG-001 in Locally Advanced or Metastatic Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type